Exploring new ways to improve and extend people’s lives
Advanced Accelerator Applications, a Novartis company partners with the patient community to discover new ways to improve and extend people’s lives. Our significant investment in research and development reinforces our commitment to using science-based innovation to address some of society’s most challenging healthcare issues. Only by working together can we improve outcomes for patients and change the practice of medicine.
The four pillars of our Commitment
Respecting and understanding the patient community perspective
Expanding access toour medicines
Conducting responsible clinical trials
Recognizing the importance of transparency and reporting
We commit to actively seeking out and listening to insights from the patient community.
Visit our YouTube channel to watch our Patient & Caregiver stories and learn more about our resources.
Collaborations with Patient Organizations
As a Novartis company, we are proud that Novartis ranks #4 in PatientView’s 2019 corporate reputation survey of patient organizations.
What is nuclear medicine?
Nuclear medicine can help diagnose, evaluate, monitor and treat disease. You may have heard about nuclear medicine but you are not sure what it is, how it works, or why it is used?
Diversity in clinical trials
Diversity in clinical trials is integral to who we are at Novartis and we are working hard to improve both the diversity of patients enrolled in our clinical research and the investigators enrolled in our trials.
Learn more about Radioligand Therapy (RLT)
Advanced Accelerator Applications, a Novartis company is reimagining cancer care with radioligand therapy (RLT) for patients with advanced cancers. RLT is a form of precision nuclear medicine that may recognize and treat disease.